SOPs for Drug Discovery

This Standard Operating Procedure (SOP) outlines the systematic approach for conducting drug discovery processes. It provides detailed steps for the identification, validation, and optimization of lead compounds, ensuring a well-defined, consistent, and scientifically sound process for discovering new drugs. The purpose of this SOP is to ensure that all stages of the drug discovery process are executed efficiently, reproducibly, and in compliance with regulatory standards. It aims to provide a framework for researchers, project managers, and quality assurance teams involved in drug discovery to follow standardized practices that maximize the potential for success and mitigate risks associated with drug development.
Click to read the full article.

The purpose of this Standard Operating Procedure (SOP) is to outline the systematic approach for identifying potential drug targets in drug discovery. Target identification is a critical first step in the drug discovery process, as it involves identifying molecules (genes, proteins, or other biomolecules) that play a central role in disease mechanisms and can be modulated to produce therapeutic benefits. This SOP ensures that the process is carried out efficiently, accurately, and in compliance with industry standards, maximizing the potential for identifying viable drug targets.
Click to read the full article.

The purpose of this Standard Operating Procedure (SOP) is to outline the process for validating drug targets in drug development. Target validation is a crucial step in the drug discovery pipeline, where identified targets undergo rigorous testing to confirm their relevance and therapeutic potential. This SOP ensures that target validation is conducted using scientifically robust methods and standardized procedures, minimizing risks associated with the selection of non-relevant targets and optimizing the likelihood of successful drug development.
Click to read the full article.

The purpose of this Standard Operating Procedure (SOP) is to describe the process for identifying lead compounds in drug development. Lead compound identification is a critical step in the drug discovery process, where potential therapeutic candidates are selected from a pool of compounds for further optimization and preclinical testing. This SOP ensures that lead identification is carried out systematically, efficiently, and in compliance with regulatory standards, maximizing the chances of identifying promising candidates for further development.
Click to read the full article.

The purpose of this Standard Operating Procedure (SOP) is to describe the process for conducting High-Throughput Screening (HTS) in drug discovery. HTS is a crucial technique used to rapidly test large numbers of compounds against a biological target to identify those that exhibit desirable biological activity. This SOP ensures that HTS is conducted efficiently, reproducibly, and in compliance with regulatory guidelines, leading to the identification of promising lead compounds for further drug development.
Click to read the full article.

The purpose of this Standard Operating Procedure (SOP) is to outline the process for conducting virtual screening (VS) in drug discovery. Virtual screening is a computational technique used to identify potential drug candidates by simulating their interaction with biological targets using computational models. This SOP ensures that virtual screening is carried out systematically, efficiently, and in compliance with industry standards, providing valuable insights for the selection of promising compounds for further development.
Click to read the full article.

The purpose of this Standard Operating Procedure (SOP) is to describe the process for conducting in silico docking studies in drug discovery. In silico docking is a computational technique used to predict the binding interactions between small molecules and a target protein or nucleic acid. This SOP ensures that docking studies are conducted systematically, with appropriate software tools, and using accurate structural data to identify potential drug candidates for further experimental validation.
Click to read the full article.

The purpose of this Standard Operating Procedure (SOP) is to describe the process of applying Quantitative Structure-Activity Relationship (QSAR) modeling in drug discovery. QSAR modeling is a computational method used to predict the biological activity of chemical compounds based on their molecular structure. This SOP ensures that QSAR modeling is conducted systematically, using reliable data and computational techniques, to support the identification and optimization of lead compounds in drug development.
Click to read the full article.

The purpose of this Standard Operating Procedure (SOP) is to describe the process of applying Fragment-Based Drug Design (FBDD) in drug discovery. FBDD is a computational and experimental approach used to identify small molecule fragments that can bind to a biological target, which can then be elaborated into lead compounds. This SOP ensures that FBDD is conducted systematically, utilizing appropriate techniques, software tools, and experimental validations to identify fragments with high binding affinity and potential for drug development.
Click to read the full article.

The purpose of this Standard Operating Procedure (SOP) is to describe the process of applying Structure-Based Drug Design (SBDD) in drug discovery. SBDD is a computational method that uses the 3D structure of a target protein or nucleic acid to design molecules that can interact with the target, modulate its activity, and ultimately lead to the development of therapeutic drugs. This SOP ensures that SBDD is conducted efficiently, using validated computational techniques and experimental validation to identify lead compounds for further development.
Click to read the full article.